Related Experiment Video
Updated: Jun 24, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Community-acquired pneumonia: the U.S. perspective
1Division of Pulmonary Medicine and Critical Care Medicine, Department of Medicine, Winthrop University Hospital, Mineola, New York 11501, USA. mniederman@winthrop.org
Seminars in Respiratory and Critical Care Medicine
|March 20, 2009
Summary
Community-acquired pneumonia (CAP) is a significant cause of death, especially in older adults. U.S. guidelines address specific pathogens and differ from European recommendations for managing this serious infection.
Area of Science:
- Infectious Diseases
- Pulmonology
- Public Health
Background:
- Community-acquired pneumonia (CAP) is a leading cause of death in the U.S., particularly for individuals over 65.
- One-year mortality for hospitalized Medicare patients with CAP can reach 40%.
Purpose of the Study:
- To outline current U.S. guidelines for community-acquired pneumonia (CAP) management.
- To highlight key differences between U.S. and European/UK CAP treatment guidelines.
Main Methods:
- Review of current U.S. guidelines for CAP management (2007).
- Comparison of U.S. guidelines with European and UK approaches.
Main Results:
- U.S. guidelines emphasize unique bacteriologic patterns, including drug-resistant pneumococcus, atypical pathogens, and MRSA.
- U.S. approach differs in severity assessment, diagnostic testing, and performance measures.
- Therapy recommendations show greater focus on atypical pathogens and fluoroquinolones in the U.S.
Conclusions:
- U.S. CAP management guidelines are tailored to domestic bacteriologic patterns and patient populations.
- Distinctive features include pathogen focus, diagnostic strategies, and therapeutic choices compared to European guidelines.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps: